Skip to main content

Find Clinical Trials

Home
Conditions
Urinary Bladder Neoplasms

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

103 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Recruiting

A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

NCT06351904

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: GenesisCare North Shore St Leonards, New South Wales, Australia

The Royal Melbourne Hospital Melbourne, Victoria, Australia

Peninsula & South Eastern Haematology and Oncology Group Melbourne, Victoria, Australia

View Trial Details

Recruiting

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

NCT07036731

Conditions: Carcinoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi Syndrome, +18 more
Locations: The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029 Nanjing, Jiangsu, China

View Trial Details

Recruiting

Chemoablation for Low-Grade Bladder Cancer

NCT07019220

Conditions: Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations: Department of Urology, Medical University of Vienna Vienna, Austria

View Trial Details

Recruiting

A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

NCT06991868

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer

NCT06889623

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Shanghai Changhai Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

NCT06696794

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: The central Hospital of wuhan Wuhan, Hubei, China

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

Xiangyang Central Hospital Xiangyang, Hubei, China

View Trial Details

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC

NCT06186414

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Peking University Third Hospital Beijing, Beijing Municipality, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Harbin Medical University Cancer Hospital Haerbin, Heilongjiang, China

Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China

View all 14 locations

View Trial Details

Recruiting

A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

NCT06632964

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Recruiting

OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer

NCT05232136

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Recruiting

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

NCT06287541

Conditions: Carcinoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi Syndrome, +18 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details